Lazzari, C.; Spagnolo, C.C.; Ciappina, G.; Di Pietro, M.; Squeri, A.; Passalacqua, M.I.; Marchesi, S.; Gregorc, V.; Santarpia, M.
Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives. Curr. Oncol. 2023, 30, 3684-3696.
https://doi.org/10.3390/curroncol30040280
AMA Style
Lazzari C, Spagnolo CC, Ciappina G, Di Pietro M, Squeri A, Passalacqua MI, Marchesi S, Gregorc V, Santarpia M.
Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives. Current Oncology. 2023; 30(4):3684-3696.
https://doi.org/10.3390/curroncol30040280
Chicago/Turabian Style
Lazzari, Chiara, Calogera Claudia Spagnolo, Giuliana Ciappina, Martina Di Pietro, Andrea Squeri, Maria Ilenia Passalacqua, Silvia Marchesi, Vanesa Gregorc, and Mariacarmela Santarpia.
2023. "Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives" Current Oncology 30, no. 4: 3684-3696.
https://doi.org/10.3390/curroncol30040280
APA Style
Lazzari, C., Spagnolo, C. C., Ciappina, G., Di Pietro, M., Squeri, A., Passalacqua, M. I., Marchesi, S., Gregorc, V., & Santarpia, M.
(2023). Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives. Current Oncology, 30(4), 3684-3696.
https://doi.org/10.3390/curroncol30040280
